AV
Avai Bio, Inc.
AVAI · OTC
$0.13 +0.00% (+$0.00)
1M +6.72%
Market Cap $17.6M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.07
44.9% downside
Current Price
$0.13
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AVAI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
EV/FFO N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
Book val. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
FCF margin N/A
Quality
57 /100
Average ROIC 151.49%
ROA 229.11%
Asset turnover 0.00x
Debt
0 /100
High Current ratio 0.04x
Int. coverage -13.74x
Debt/Equity N/A
Stability
38 /100
Moderate Beta 0.87x
EPS volatility 117.23%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AVAI
Online
Sector
Technology
Industry
Software - Application
CEO
Chris Winter
Employees
1
Headquarters
Vilnius